PTGX Protagonist Therapeutics PE ratio, current and historical analysis

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 99

As at Nov 16, 2026, the PTGX stock has a PE ratio of 24.24. This is based on the current EPS of $5.15 and the stock price of $124.83 per share.

PTGX PE ratio history

How has PTGX's PE ratio performed in the past

The mean historical PE ratio of Protagonist Therapeutics over the last ten years is 41.31. The current 24.24 PE ratio is 41% below the historical average. Over the past ten years, PTGX's PE ratio was at its highest in the Jun 2026 quarter at 101.31, with a price of $122.58 and an EPS of $1.21. The Dec 2024 quarter recorded the bottom point at 8.64, with a price of $38.6 and an EPS of $4.47.

Today
24.21
Average
41.31
Median
27.36
Minimum
8.64
Maximum
101.31

Protagonist Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2025 N/A N/A $87.34 -$2.05
2024 8.64 N/A $38.6 $4.47
2023 N/A N/A $22.93 -$1.39
2022 N/A N/A $10.91 -$2.6
2021 N/A N/A $34.2 -$2.71
2020 N/A N/A $20.16 -$1.92
2019 N/A N/A $7.05 -$2.98
2018 N/A N/A $6.73 -$1.74
2017 N/A N/A $20.8 -$2.09
2016 N/A N/A $21.99 -$5.8
2015 N/A N/A N/A -$59.32
2014 N/A N/A N/A -$49.38

Protagonist Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Sep 2026 27.36 -72.99% $140.89 $5.15
Jun 2026 101.31 N/A $122.58 $1.21
Mar 2026 N/A N/A $105.4 -$1.81
Dec 2025 N/A N/A $87.34 -$2.05
Sep 2025 86.27 32.68% $66.43 $0.77
Jun 2025 65.02 21.01% $55.27 $0.85
Mar 2025 53.73 521.88% $48.36 $0.9
Dec 2024 8.64 -44.51% $38.6 $4.47
Sep 2024 15.57 28.04% $45 $2.89
Jun 2024 12.16 12.18% $34.65 $2.85
Mar 2024 10.84 N/A $28.93 $2.67
Dec 2023 N/A N/A $22.93 -$1.39
Sep 2023 N/A N/A $16.68 -$2.63
Jun 2023 N/A N/A $27.62 -$2.69
Mar 2023 N/A N/A $23 -$2.85

PTGX Price vs fair value

How does PTGX's price compare to its estimated fair value based on its growth

PTGX average PE ratio chart

What is the average PE ratio of PTGX for the past years

PTGX's current P/E ratio is below the 3, 5 and 10-year averages.

3-year avg
42.32
5-year avg
42.32
10-year avg
41.31
15-year avg
N/A

PE comparison

Protagonist Therapeutics's P/E of 24.24 is above the industry average but below the Healthcare sector average. But compared to its Healthcare sector average of 25.05, Protagonist Therapeutics's P/E is only 3.2% lower.

PTGX PE vs peers

What is PTGX's PE ratio compared to its peers

Frequently asked questions

What is Protagonist Therapeutics's PE ratio?

The price to earnings ratio for PTGX stock is 24.24 as of Nov 16, 2026.

What is the 3-year average PE ratio for Protagonist Therapeutics (PTGX)?

The 3-year average PE ratio for PTGX stock is 42.32.

What is the 5-year average PE ratio for Protagonist Therapeutics (PTGX)?

The 5-year average PE ratio for PTGX stock is 42.32.

What is the highest PE ratio for PTGX?

The highest quarterly PE ratio in the last ten years has been 101.31 and it was in the Jun 2026 quarter.

How does the current PE ratio for PTGX compare to its historical average?

PTGX's current price to earnings ratio is 41% below its 10-year historical average.

How is PTGX's PE ratio calculated (Protagonist Therapeutics PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Nov 16, 2026), Protagonist Therapeutics's stock price is $124.83. The earnings per share for the trailing twelve months (TTM) ending Sep 2026 is $5.15. Therefore, Protagonist Therapeutics's P/E ratio for today is 24.24. PE RATIO(24.24) = STOCK PRICE($124.83) / TTM EPS($5.15)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.